What happened, in summary

A 67-year-old woman was initially treated endoscopically for a small rectal neuroendocrine tumor. One year later, surveillance CT found a mass in the right lung. Partial lobectomy showed a separate Stage I lung adenocarcinoma.

The lung cancer later recurred, and systemic chemotherapy was started. Years later, liver lesions were proven to be metastases from the rectal neuroendocrine tumor rather than from the lung adenocarcinoma, so they remain separate from the lung-cancer journey.

The patient continued to be followed over many years while both malignancies were managed. Ultimately, she died from progression of the lung cancer 13 years after the original rectal procedure. Because the lung cancer was diagnosed one year after that procedure, this corresponds to about 12 years living after the lung-cancer diagnosis. Her course underscores the importance of keeping two separate primary cancers and their later disease events distinct.